BioPharma Pharma & Biopharma Manufacturing
“We are excited about the strategic manufacturing partnership with Richter-Helm BioLogics. As a leading manufacturer of DNA vaccines, they will provi...
December 20, 2022 | News
Thermo Fisher Scientific, the world leader in serving science, is opening a new facility in Hangzhou, China, as part of its global effort to help comp...
December 08, 2022 | News
GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, is partnering with Allozymes, a Singap...
December 07, 2022 | News
The Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI) has chosen Lonza’s MODA-ES® Manufacturing Execution System (M...
December 06, 2022 | News
This new line features a fully automatic vial loading/unloading system and a built-in 15 m2 lyophilizer in a fully enclosed isolator. The filling line...
December 01, 2022 | News
The biomanufacturing sector is experiencing a digitalization transformation that is aligned with Industry 4.0. According to Frost & Sullivan's recent a...
November 30, 2022 | News
-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in S...
November 28, 2022 | News
WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmaceutical East China R&D facility in tandem with the signing ceremony...
November 24, 2022 | News
Kamada Ltd., a leading global biopharmaceutical company, has a well-established infrastructure for marketing, sales, and distribution of commercial pharmac...
November 24, 2022 | News
Snapdragon specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation techn...
November 22, 2022 | News
First mRNA manufacturing facility in Singapore will create regional manufacturing capacities in support of BioNTech’s growing pipeline of...
November 14, 2022 | News
We tend to put off investments in improvements and instead opt to play it safe, taking a conservative approach to weathering the economic storm. For ...
November 01, 2022 | News | By Michelle Tanner, CFO, MasterControl
Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining lo...
October 26, 2022 | News
Facility will enhance Aragen’s offerings in clinical formulation development and manufacturing Will offer both integrated and stand-alone formulat...
October 21, 2022 | News
Most Read
Bio Jobs
News